These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27583064)

  • 1. Cranberry proanthocyanidins modulate reactive oxygen species in Barrett's and esophageal adenocarcinoma cell lines.
    Weh KM; Aiyer HS; Howell AB; Kresty LA
    J Berry Res; 2016; 6(2):125-136. PubMed ID: 27583064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention.
    Kresty LA; Clarke J; Ezell K; Exum A; Howell AB; Guettouche T
    J Carcinog; 2011; 10():34. PubMed ID: 22279419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation.
    Kresty LA; Weh KM; Zeyzus-Johns B; Perez LN; Howell AB
    Oncotarget; 2015 Oct; 6(32):33438-55. PubMed ID: 26378019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cranberry proanthocyanidins induce apoptosis and inhibit acid-induced proliferation of human esophageal adenocarcinoma cells.
    Kresty LA; Howell AB; Baird M
    J Agric Food Chem; 2008 Feb; 56(3):676-80. PubMed ID: 18211022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cranberry Polyphenols in Esophageal Cancer Inhibition: New Insights.
    Weh KM; Zhang Y; Howard CL; Howell AB; Clarke JL; Kresty LA
    Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, modulation, and clinical correlates of the autophagy protein Beclin-1 in esophageal adenocarcinoma.
    Weh KM; Howell AB; Kresty LA
    Mol Carcinog; 2016 Nov; 55(11):1876-1885. PubMed ID: 27696537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.
    Chemnitzer O; Götzel K; Maurer L; Dietrich A; Eichfeld U; Lyros O; Jansen-Winkeln B; Hoffmeister A; Gockel I; Thieme R
    Dig Dis Sci; 2017 Dec; 62(12):3391-3401. PubMed ID: 29086334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome.
    Weh KM; Howard CL; Zhang Y; Tripp BA; Clarke JL; Howell AB; Rubenstein JH; Abrams JA; Westerhoff M; Kresty LA
    JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38329812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome.
    Weh KM; Howard CL; Zhang Y; Tripp BA; Clarke JL; Howell AB; Rubenstein JH; Abrams JA; Westerhoff M; Kresty LA
    bioRxiv; 2023 Aug; ():. PubMed ID: 37662411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-depth characterization of the Wnt-signaling/β-catenin pathway in an in vitro model of Barrett's sequence.
    Götzel K; Chemnitzer O; Maurer L; Dietrich A; Eichfeld U; Lyros O; Moulla Y; Niebisch S; Mehdorn M; Jansen-Winkeln B; Vieth M; Hoffmeister A; Gockel I; Thieme R
    BMC Gastroenterol; 2019 Mar; 19(1):38. PubMed ID: 30841855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton Pump Inhibitors Display Antitumor Effects in Barrett's Adenocarcinoma Cells.
    Chueca E; Apostolova N; Esplugues JV; García-González MA; Lanas Á; Piazuelo E
    Front Pharmacol; 2016; 7():452. PubMed ID: 27932981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proanthocyanidins mitigate bile acid-induced changes in GSTT2 levels in a panel of racially diverse patient-derived primary esophageal cell cultures.
    Weh KM; Turgeon DK; Rubenstein JH; Clarke JL; Howell AB; Chang AC; Kresty LA
    Mol Carcinog; 2022 Mar; 61(3):281-287. PubMed ID: 34758158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model.
    Zhang Y; Weh KM; Tripp BA; Clarke JL; Howard CL; Sunilkumar S; Howell AB; Kresty LA
    Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cells.
    Kim KK; Singh AP; Singh RK; Demartino A; Brard L; Vorsa N; Lange TS; Moore RG
    Int J Oncol; 2012 Jan; 40(1):227-35. PubMed ID: 21922132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purified cranberry proanthocyanidines (PAC-1A) cause pro-apoptotic signaling, ROS generation, cyclophosphamide retention and cytotoxicity in high-risk neuroblastoma cells.
    Singh AP; Lange TS; Kim KK; Brard L; Horan T; Moore RG; Vorsa N; Singh RK
    Int J Oncol; 2012 Jan; 40(1):99-108. PubMed ID: 21994123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in mitochondrial stability during the progression of the Barrett's esophagus disease sequence.
    O'Farrell NJ; Feighery R; Picardo SL; Lynam-Lennon N; Biniecka M; McGarrigle SA; Phelan JJ; MacCarthy F; O'Toole D; Fox EJ; Ravi N; Reynolds JV; O'Sullivan J
    BMC Cancer; 2016 Jul; 16():497. PubMed ID: 27431913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Obstructive Pulmonary Disease and the Risk of Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Primary Care Case-Control Study.
    Menon S; Nightingale P; Trudgill N
    J Clin Gastroenterol; 2019; 53(10):e451-e455. PubMed ID: 31008868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AXL Promotes Metformin-Induced Apoptosis Through Mediation of Autophagy by Activating ROS-AMPK-ULK1 Signaling in Human Esophageal Adenocarcinoma.
    Hong J; Maacha S; Pidkovka N; Bates A; Salaria SN; Washington MK; Belkhiri A
    Front Oncol; 2022; 12():903874. PubMed ID: 35936716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.